Zentalis presents corporate deck at conferences; no new financial or clinical updates disclosed

Zentalis Pharmaceuticals, Inc.

Spokespersons to present the April 2024 corporate presentation at investor meetings and conferences.
Presentation furnished as Exhibit 99.1; no specific material changes or new data provided.
Filing under Regulation FD; information is furnished not filed.

item 7.01 item 9.01

Zentalis Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001725160-24-000082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.